Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and effectiveness of Ammonul® in
subjects who become hospitalized with Grade 3 or 4 hepatic encephalopathy (HE).